News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

KAITE KAMMERS, PHARMD, BCPS

Advertisement

Articles by KAITE KAMMERS, PHARMD, BCPS

Exploring Primary Prophylaxis for Invasive Pulmonary Aspergillosis

ByRYAN W. STEVENS, PHARMD, BCIDP, BCPS,KAITE KAMMERS, PHARMD, BCPS
December 11th 2018

Invasive aspergillosis affects up to 13% of immunocompromised patients who are in the hospital.

Advertisement

Latest Updated Articles

  • Exploring Primary Prophylaxis for Invasive Pulmonary Aspergillosis
    Exploring Primary Prophylaxis for Invasive Pulmonary Aspergillosis

    Published: December 11th 2018 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Listeria Outbreak Update: 27 Illnesses and 6 Deaths Linked to Packaged Meals

2

In A Matter of Months, MMR Vaccine Confidence Drops Significantly

3

Global Collaboration and Immune-Based Innovation Take Center Stage in AMR Development

4

Peggy Lillis Foundation Launches “See C diff” Campaign as National C diff Awareness Month Begins

5

FDA Approves IV Antbiotic, Contepo, for Complicated Urinary Tract Infections

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us